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The presence of DNA in the cytoplasm is a danger
signal that triggers immune and inflammatory re-
sponses. Cytosolic DNA binds to and activates cyclic
GMP-AMP (cGAMP) synthase (cGAS), which pro-
duces the second messenger cGAMP. cGAMP binds
to the adaptor protein STING and activates a
signaling cascade that leads to the production of
type I interferons and other cytokines. Here, we
report the crystal structures of human cGAS in its
apo form, representing its autoinhibited conforma-
tion as well as in its cGAMP- and sulfate-bound
forms. These structures reveal switch-like conforma-
tional changes of an activation loop that result in the
rearrangement of the catalytic site. The structure of
DNA-bound cGAS reveals a complex composed of
dimeric cGAS bound to twomolecules of DNA. Func-
tional analyses of cGAS mutants demonstrate that
both the protein-protein interface and the two DNA
binding surfaces are critical for cGAS activation.
These results provide insights into the mechanism
of DNA sensing by cGAS.
INTRODUCTION
Infectious microorganisms contain and need nucleic acids in
their life cycles. The innate immune system has evolved to
recognize microbial DNA and RNA as an essential strategy for
host defense (Takeuchi and Akira, 2010). Following endocy-
tosis, microbial DNA and RNA can be detected in the endo-
some by the transmembrane Toll-like receptors, which then
initiate signal transduction cascades in the cytoplasm that
lead to activation of the transcription factors NF-kB and
interferon regulatory factors (IRFs; e.g, IRF3 and IRF7). These
transcription factors then enter the nucleus to induce type I in-
terferons (IFNs) and other antimicrobial molecules. For thoseCmicrobes that have succeeded in invading and replicating in-
side the host cells, the microbial DNA and RNA are detected
in the cytoplasm by the innate immune systems. Viral RNA,
which usually contains 50-triphosphate and/or the double-
stranded RNA (dsRNA) structure, is detected by the RIG-I family
of receptors (Rehwinkel and Reis e Sousa, 2010; Yoneyama
and Fujita, 2009). RIG-I then activates NF-kB and IRFs through
the mitochondrial adaptor protein MAVS (also known as IPS-1,
VISA, or CARDIF).
We recently identified cyclic GMP-AMP synthase (cGAS) as
the cytosolic DNA sensor that triggers type I IFN production
(Sun et al., 2013; Wu et al., 2013). cGAS binds to microbial
DNA as well as self DNA in a sequence-independent manner,
whichmay allow this DNA sensor to detect any DNA that invades
the cytoplasm. Upon DNA binding, cGAS is activated to catalyze
the synthesis of a unique isomer of cyclic GMP-AMP (cGAMP)
from ATP and GTP. This cGAMP isomer contains two phospho-
diester bonds: one between 20-OH of GMP and 50-phosphate of
AMP, and the other between 30-OH of AMP and 50-phosphate of
GMP (Ablasser et al., 2013; Diner et al., 2013; Gao et al., 2013b;
Zhang et al., 2013). This cGAMP, termed 2030-cGAMP, functions
as a second messenger that binds to the endoplasmic reticulum
membrane protein STING (also known as MITA, MPYS, or ERIS)
(Barber, 2011; Wu et al., 2013; Zhang et al., 2013). This binding
induces a conformational change of STING, which then recruits
the kinases IKK and TBK1 to activate NF-kB and IRF3, respec-
tively (Ishikawa and Barber, 2008; Tanaka and Chen, 2012).
Recent genetic studies have validated the essential role of
cGAS in sensing cytosolic DNA in multiple cell types and in
immune defense against DNA viruses in vivo (Li et al., 2013b).
In addition, cGAS has been shown to be an innate immune
sensor of retroviruses, including HIV (Gao et al., 2013a).
In this study, we investigated the mechanism by which cGAS
is activated by DNA through crystallographic and biochemical
approaches. We determined the human cGAS structures in their
apo form, which represents the autoinhibited conformation,
as well as in their 2030-cGAMP-bound and sulfate-bound
forms, which are captured in a locally activated conformation,
as compared with the mouse cGAS-DNA complex. On the basisell Reports 6, 421–430, February 13, 2014 ª2014 The Authors 421
of these structures, we identified a conserved activation loop
in cGAS, located near the primary DNA binding surface, that
exhibits switch-like conformational changes after DNA binding.
Surprisingly, in contrast to recent structural analyses, which
focused on a cGAS-DNA complex that contains one molecule
of cGAS and one molecule of DNA (Civril et al., 2013; Gao
et al., 2013b; Kranzusch et al., 2013), we found that cGAS
forms a 2:2 complex with DNA. Mutagenesis experiments
demonstrated that the two DNA binding surfaces and the pro-
tein-protein interface of cGAS are important for IRF3 activation
and IFNb induction.
RESULTS
Overall Structure of cGAS in the Apo Form
Human cGAS contains 522 amino acid residues, in which the N
terminus containing approximately 160 residues is predicted to
be unstructured and was previously shown to be dispensable
for DNA-dependent cGAMP synthesis (Sun et al., 2013). We ex-
pressed a truncated human cGAS (residues 147–522) in E. coli
as a SUMO fusion protein and purified it after removal of the
SUMO tag. We determined the crystal structure of this human
cGAS protein in its apo form at 2.45 A˚ using the selenomethio-
nine derivative (Figures S1 and S2A; Table S1). Similarly to the
recently reported structures of cGAS from different species
(Civril et al., 2013; Gao et al., 2013b; Kranzusch et al., 2013),
human cGAS adopts an overall fold of mixed a/b topology, which
is composed of two lobes (Figure 1A, left and middle). The N-ter-
minal lobe comprises a series of central-twisted b sheets (b1–b9)
flanked by a1–a7 helices. The C-terminal lobe is a compact
a-helix bundle (a8–a12), including a conserved zinc binding
motif. The catalytic residues (Glu225, Asp227, and Asp319) are
located on the central b sheet, the side chains of which point
to the cleft between the N lobe and C lobe. Two residues
(Gly212 and Ser213) are in a highly conserved loop region, con-
necting the first and second b strands (b1 and b2; Figure 1A,
right). Mutations of Gly212 and Ser213 to alanine abolish the
cGAS activity (Sun et al., 2013), underscoring the functional
significance of this loop region. Herein, we refer to this loop (res-
idues 210–220 in human cGAS; Figure S1) as the activation loop
(see details below).
The Structure of cGAS in Complex with 2030-cGAMP
We attempted to cocrystallize human cGAS in complex with
double-stranded DNA (dsDNA), but failed to obtain well-diffract-
ing crystals. In the meantime, we were able to obtain well-
diffracting crystals of cGAS (residues 161–522) bound to its
product 2030-cGAMP. We determined the structure of this com-
plex by molecular replacement (MR), using apo cGAS as the
search model, and refined it to 2.44 A˚ with good Rfree values
and stereochemistry (Figure S2B; Table S1). A simulated anneal-
ing omit map and 2Fo-Fc electron density map revealed decent
density for 2030-cGAMP (Figure 1B). 2030-cGAMP sits at the lower
part of the cleft between the N lobe and C lobe (Figure 1C, left).
The catalytic residues Asp227 and Asp319, in addition to
Lys362, Arg376, and Ser434, interact with 2030-cGAMP through
multiple polar contacts (Figure 1C, right). The base group of
adenine moiety stacks against the aromatic residue Tyr436422 Cell Reports 6, 421–430, February 13, 2014 ª2014 The Authors(Figure 1D). The residues involved in 2030-cGAMP binding are
identical to the corresponding residues identified in the recently
determined structure of mouse cGAS that contains a 16-bp
dsDNA in addition to 2030-cGAMP (Protein Data Bank ID code
[PDB] 4K9B; Figure 1D; Gao et al., 2013b).
The Structure of cGAS in Complex with Sulfate Ions
We crystallized human cGAS (161–522) in the presence of 2 M
(NH4)2SO4 and refined the structure to 2.25 A˚ (Figure S2C; Table
S1). During the structure refinement, two pieces of spherical
electron density were observed in the cleft between the N lobe
andC lobe (Figure 1E). They likely represent sulfate ions because
of the crystallization condition. Sulfate ions are often utilized to
mimic phosphate groups and interact with the phosphate bind-
ing site in order to trap specific conformations of kinase or nucle-
otide cyclase (Jeong et al., 2003; Tanaka et al., 2010). After fitting
two sulfate ions in the cleft, we found that the first sulfate ion, in
the upper part of the cleft, was well coordinated by the sur-
rounding residues Ser213, Lys414, and Ser435 (Figure 1F). If
the sulfate-bound cGAS structure is superimposed with the
mouse-cGAS-DNA-linear-20-GTP-GMP ternary complex (PDB
4K98), the first sulfate ion is located in a position similar to that
of the g-phosphate group in the GTP moiety, whereas the sec-
ond ion sits near the a-phosphate group in the GMPmoiety (Fig-
ure 1G). The structural similarity among cGAMP-bound human
cGAS, sulfate-bound human cGAS, and DNA-bound mouse
cGAS suggests that cGAS is trapped in a locally activated
conformation in the presence of 2030-cGAMP or sulfate ions.
Conformational Changes in the Activation Loop of cGAS
A comparison of the activation loops in apo cGAS and the other
two ligand-bound cGAS structures reveals that the loop un-
dergoes significant conformational changes (Figure 2A). The
activation loop is not involved in the crystal-packing interface
(Figures S3A–S3C). The 2Fo-Fc electron density maps of the acti-
vation loops of apo cGAS and sulfate-bound cGAS are of decent
quality (Figure 2B). The sulfate ion in the upper part of the cleft
interacts directly with Ser213 in the activation loop (Figure 1F),
resulting in a fixed loop orientation. However, the activation
loop in the cGAMP-bound cGAS structure appears relatively
more flexible (Figure 2A), probably because 2030-cGAMP binds
to the lower part of the cleft and releases the activation loop to
some extent (Figure 1C).
The conformational changes of the activation loop include not
only an inward movement of the protruded loop (Gly212 and
Ser213) but also an outward shift of Val218 and Lys219 in order
to empty the pocket for the substrates (in this case, the sulfate
ions that mimic the phosphate moieties of nucleotides; Figures
2C and 2D; Movie S1). Besides the rearrangement in the cleft
of the active site, the N lobe also exhibits conformational
shifts, especially in a2, a4, and the b sheet formed by b5, b6,
b7, and b2 (Figures 2E and 2F; Movies S2 and S3). This region
exhibits high B factors, suggesting relatively high mobility
(Figure S3D).
The large conformational change of the activation loop from
apo cGAS to sulfur-bound cGAS raises the question of how
such conformational change is triggered. On the backside of
the cleft, there is one positively charged patch, which was
Figure 1. Overall Structures of Human cGAS in the apo Form or in Complex with 2030-cGAMP or Sulfate Ions
(A) Overall structure of human cGAS in the apo form. The catalytic residues are shown in sticks. Two perpendicular views and a close-up view of the conserved
loop connecting the first and second b strands are shown. The residues in the loop are shown in sticks.
(B) The simulated annealing omit map (top) and the 2Fo-Fc electron density map (bottom) for 2
030-cGAMP are contoured at 3.0 s and 1.0 s, respectively.
(C) Overall structure of cGAS in complex with 2030-cGAMP (left). The cleft between the N lobe and C lobe is highlighted by a green rectangle. 2030-cGAMP binds to
cGAS by multiple polar contacts (right).
(D) Residues involved in 2030-cGAMP binding are identical to the ones in mouse-cGAS-DNA-2030-cGAMP ternary complex (PDB 4K9B).
(E) The simulated annealing omit map (top) and the 2Fo-Fc electron density map (bottom) for the sulfate ions are contoured at 4.0 s and 1.5 s, respectively.
(F) Overall structure of cGAS in complex with sulfate ions (left). The cleft between the N lobe and C lobe is highlighted by a green rectangle. Sulfate ion 1 is
coordinated by several polar residues (right).
(G) Residues involved in sulfate ion binding are conserved in mouse-cGAS-DNA-linear-20-GTP-GMP ternary complex (PDB 4K98). The position of sulfate ion 1 is
similar to the g-phosphate group of GTPmoiety, whereas the position of sulfate ion 2 is similar to the a-phosphate group of GMPmoiety. All of the structure figures
were prepared in PyMol (DeLano, 2002).
See also Figures S1 and S2.recently shown to bind DNA (Civril et al., 2013; Gao et al., 2013a;
Kranzusch et al., 2013). Interestingly, the activation loop,
pointing outward in apo cGAS, hinders the interaction betweenChuman cGAS andDNA (Figure 3A). The sulfate ions trap a confor-
mation that displays several positively charged patches and is
able to accommodate the modeled dsDNA helix (Figure 3B).ell Reports 6, 421–430, February 13, 2014 ª2014 The Authors 423
Figure 2. Ligand-Induced Conformational Changes of the Activation Loop and Active-Site Rearrangement of cGAS
(A) Comparison of the activation loops in apo cGAS (cyan), sulfate-bound cGAS (magenta), and cGAMP-bound cGAS (orange). The loop of cGAMP-bound cGAS
is shown by a dashed line because of its high flexibility. Two perpendicular views are shown. The same color scheme is applied unless indicated otherwise.
(B) The 2Fo-Fc electron density maps of the activation loop in apo cGAS (left) or sulfate-bound cGAS (right), shown in blue mesh, are contoured at 0.8 s.
(C) The activation loop undergoes significant conformational changes in the presence of sulfate ions (right) compared with apo cGAS (left). a2 helix is used as the
reference.
(D) Val218 and Lys219 (yellow) occupy a large part of the cleft between the N lobe and C lobe in apo cGAS. The sulfate ions are shown in red spheres in the right
panel.
(E and F) The N lobe of cGAS exhibits distinguishable conformational shifts in the presence of 2030-cGAMP (E) or sulfate ions (F) as compared with the apo form.
See also Figure S3 and Movies S1, S2, and S3.
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We examined a series of conserved positively charged resi-
dues located on the potential DNA binding surface by mutagen-
esis. Expression plasmids encoding wild-type or mutant human
cGAS were transfected into human embryonic kidney 293T
(HEK293T) cells stably expressing STING and an IFNb-luciferase
reporter. Luciferase activity and IRF3 dimerization assays show
that Lys384, Lys407, and Lys411 are critical for cGAS function
(Figure 3C). Lys407 and Lys411 are located on the preexisting
positively charged patch, whereas Lys384 is near the activation
loop and is exposed only in sulfate-bound cGAS (Figure 3D).
Notably, mutations of several positively charged residues in
the first and second a helices (R166A, K187A, and K198A) of
cGAS did not abrogate its ability to induce IFNb or activate
IRF3 (Figure 3C).
Modeling of the cGAS structures bound to the B-form dsDNA
shows that the DNA binding clashes with the protruded activa-
tion loop, causing this loop to move inward and rearrange the
active site (Figure 3E; Movie S1). In contrast, modeling using
the A-form dsRNA shows that the activation loop inserts into
the major groove of dsRNA without causing detectable con-
formational changes (Figure 3F), which may explain why cGAS
cannot be activated by dsRNA.
cGAS Forms a 2:2 Functional Complex with DNA
To further understand how DNA binding activates cGAS, we
solved the crystal structure of mouse cGAS in the presence of
DNA. The same mouse cGAS protein and DNA were previously
used to obtain the crystal structure of a cGAS-DNA complex,
which was interpreted to contain one cGAS and one DNA (Gao
et al., 2013b). However, we found that each asymmetric unit con-
tains two cGAS molecules and two DNA molecules (Figure 4A).
Besides the primary DNA binding surface (surface 1), which is
identical to the ones reported previously (see also Figures 3B
and 3D) (Civril et al., 2013; Gao et al., 2013b), cGAS has another
surface area, composed of two positive patches, that interacts
with DNA (Figure 4B).
Closer inspection of the apo- and sulfate-bound human
cGAS also reveals a dimer in the crystal (Figures S4A and
S4B). Interestingly, Lys394 within the zinc finger of human
cGAS, corresponding to Lys382 in mouse cGAS, interacts
with the carbonyl oxygen atoms of Asn389 and Gly391 (Fig-
ure 4C). Lys347 in human cGAS (Lys335 in mouse cGAS) not
only mediates DNA binding (Figure 4B) but also interacts
with Glu398 from the adjacent protomer (Figure 4C). The inter-
action area is about 678 A˚2 in total, suggesting a weak interac-
tion, which may be reinforced by the binding of cGAS to DNA.
Although it was not reported previously, the same dimer inter-
face exists in the previously published crystal structures of
apo- and DNA-bound cGAS proteins from different species
and crystallized under different conditions (Figures S4C–S4F)
(Civril et al., 2013; Gao et al., 2013a; Kranzusch et al., 2013),
strongly suggesting that the formation of cGAS dimer is not
a crystallographic artifact. Indeed, we found that Flag-cGAS
and hemagglutinin (HA)-cGAS coimmunoprecipitated from
HEK293T cells that expressed both of these proteins, suggest-
ing that cGAS may form a dimer or oligomer in mammalian
cells, perhaps in the presence of the transfected plasmid
DNA (Figure S4G).CAnalytical ultracentrifugation (AUC) sedimentation velocity
(SV) experiments were performed to examine the hydrodynamic
behavior of mouse cGAS (m-cGAS) in the absence and presence
of DNA. Without DNA in solution, m-cGAS is a monomer that
sediments at 3.2 S at all concentrations (0.8–80 mM) studied
(Figure S4H). Thus, the m-cGAS dimer observed in the crystal
structures in the absence of DNA may be due to the very high
concentrations of cGAS under the crystallographic conditions.
However, in the presence of a 16-mer dsDNA, faster-sediment-
ing complexes are evident at 4.0 S, 5.3 S, and 6.5 S (Figure 4D).
The latter peak is close to that expected for a 2:2 complex. A
multisignal SV (Balbo et al., 2005; Padrick et al., 2010) analysis
demonstrates that the molar ratio of protein:DNA in this peak is
0.9:1 (Figure S4I). Thus, the hydrodynamics and composition
of this peak are consistent with the formation of the postulated
2:2 complex. The high concentrations needed to achieve this
complex (80 mM protein, 120 mM DNA) reflect the apparently
poor association constant of complex formation. The other
fast-sedimenting peaks mentioned here are likely DNA and pro-
tein whose time-average sedimentation coefficients have been
increased (resulting in ‘‘advanced species’’) by brief residencies
in complexes between the two.
The conclusion that the 6.5 S peak represents 2:2 complexes
is further buttressed by parallel experiments carried out with
the m-cGAS point mutant K335E (corresponding to K347 in hu-
man cGAS). As mentioned above, this residue mediates both
cGAS-cGAS and cGAS-DNA interactions (Figure 4C). Under
similar conditions (94 mM protein, 120 mMDNA), this mutant pro-
tein does not form fast-sedimenting complexes as efficiently as
the wild-type m-cGAS (Figure 4D). Although this mutant effi-
ciently binds DNA, its ability to form large complexes is greatly
diminished, and thus the population of 2:2 complexes must be
significantly smaller than that observed in the experiment with
wild-type cGAS. It appears, therefore, that Lys335 is very impor-
tant for the formation of the protein-protein interface, but its
mutation does not disrupt DNA binding, likely because the intact
DNA binding surface 1 and the other residues in the DNA binding
surface 2 can still mediate DNA binding. The resolved peaks in
this analysis likely consist of a combination of effective particles
(Schuck, 2010) containing various populations of possible com-
plexes and advanced species (Figure 4D, green curve).
In cell-based functional assays, point mutations of Lys347
(Lys335 in m-cGAS), Arg353, or Lys394 to Glu in the human
cGAS completely abolished its ability to activate IRF3 and
induce IFNb (Figure 4E). Although single mutations of Arg232,
Lys254, and Lys327 to Glu only partially impaired the activity
of cGAS, double (R236E/K254E and K254E/K327E) and triple
(R236E/K354E/K327E) mutations abolished the activity. These
results indicate that the second DNA binding site and the pro-
tein-protein interface in cGAS are important for activation of
the type I IFN pathway (Figure S4J; Movie S4).
DISCUSSION
In this study, we determined the crystal structures of human
cGAS in its apo form, 2030-cGAMP-bound form, and sulfate-
bound form. Structural alignment with the DNA-bound mouse
cGAS shows that the ligand-bound human cGAS resemblesell Reports 6, 421–430, February 13, 2014 ª2014 The Authors 425
(legend on next page)
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the activated conformation induced by DNA binding. In apo
cGAS, the activation loop points to the outside. Once cGAS
encounters cytosolic B-form DNA, the preexisting positively
charged patch (Lys407, Lys411, and other DNA binding residues
on a1 and a2 helices) ‘‘grabs’’ the DNA. The steric clash between
the DNA and the activation loop ‘‘switches on’’ dramatic con-
formational changes in the loop region such that new positively
charged patches are formed, including the exposure of
Lys384, allowing further DNA binding (Figure 3E; Movie S1).
The DNA binding causes the activation loop to move inward,
thus rearranging the active site to catalyze cGAMP formation
(Movie S4).
While wewere refining the cGAS structures, three groups pub-
lished the crystal structures of cGAS (Civril et al., 2013; Gao
et al., 2013b; Kranzusch et al., 2013). Gao et al. (2013b) and Civril
et al. (2013) determined the crystal structures of mouse cGAS
and porcine cGAS, respectively, in both the apo form and
DNA-bound form. Both groups observed that the first and sec-
ond helices bind to DNA and undergo conformational shifts.
Although Gao et al. (2013b) showed that none of the single-point
mutations of the positive residues on a1 and a2 helices abro-
gated the DNA-dependent activity of cGAS, Civril et al. (2013)
found that the doublemutant K173A/R176A on a1 helix of human
cGAS had greatly reduced activity. More recently, Li et al.
(2013a) showed that R158E of mouse cGAS (equivalent to
K173 of human cGAS) was largely defective in cGAMP synthesis
and IFNb induction. Thus, DNA binding to the first two a helices
of cGAS likely contributes to its activation. However, this is not
sufficient. Here we show that the switch-like movement of the
activation loop, which is triggered in part by DNA binding to
the positively charged residues (K384, K407, and K411) located
in a7 and a8 surrounding the zinc finger, mediates cGAS activa-
tion. Contrary to our results, which showed that K384A or K407A
mutation abolished cGAS activity, Gao et al. (2013b) found that
mutations of the corresponding residues in mouse cGAS did
not impair its activity. However, two recent reports presented
evidence showing that point mutations of K384, K407, and
K411 in human cGAS or the corresponding residues in mouse
cGAS abolished its ability to induce IFNb (Kato et al., 2013; Li
et al., 2013a).
Interestingly, mouse cGAS is able to tolerate G199A muta-
tion, but G199P or G199AS200A largely abolishes its activity
(Sun et al., 2013; Gao et al., 2013b), suggesting a crucial role
of the loop flexibility in the activation process. The S200A mu-
tation has little effect on cGAS activity, presumably because it
does not affect the loop flexibility, and the binding of the g-
phosphate group from the substrate (sulfate ion in our structure)Figure 3. The Primary DNA Binding Surface of cGAS Is Essential for IF
(A and B) Electrostatic representations of apo cGAS (A) and sulfate-bound cGAS
potential primary DNA binding surface.
(C) Expression plasmids encoding wild-type (WT) and variousmutants of human c
residues shown in (B) were transfected into HEK293T-STING-IFNb luciferase rep
the cell extracts were immunoblotted with an IRF3 antibody following native gel e
The error bars represent variation ranges of duplicate experiments.
(D) Functionally important positively charged residues, shown in green sticks, ar
(E and F) Docking B-form DNA to apo cGAS (E) results in a steric clash between th
activation loop. However, docking A-form RNA to apo cGAS (F) does not reveal
colored in cyan. Loss-of-function mutations on the primary DNA binding surface
Cinvolves multiple polar contacts besides the interaction with
S200 (S213 in human cGAS). Kranzusch et al. (2013) deter-
mined the crystal structure of human cGAS in its apo form.
The activation loop in this structure also protrudes to the
outside, even though the cGAS protein fragment and the crys-
tallization conditions were distinct from what were used in our
study, suggesting that the outward protrusion of the activation
loop in human cGAS is reproducible in different crystals.
Although the protrusion of the activation loop is less obvious
in mouse cGAS, the significant ligand-induced conformational
switch of the activation loop occurs in both human and mouse
cGAS structures.
cGAS is not the only protein that possesses an activation loop.
A conserved activation segment, starting with the DFGmotif and
endingwith the APEmotif, exists in all protein kinase families and
is also crucial for catalytic activity (Endicott et al., 2012). The DFG
loop has been shown to be an important drug target. The identi-
fication of the activation loop in cGAS reveals a mechanism of its
activation by DNA and may assist in the development of cGAS
inhibitors.
Surprisingly, we found that the cGAS structures we deter-
mined and those that were published previously all form an iden-
tical dimer in the crystal (Figures 4 and S4) (Civril et al., 2013; Gao
et al., 2013a; Kranzusch et al., 2013). These findings indicate
that cGAS itself may form a dimer. However, our AUC analysis
shows that the mouse cGAS protein does not form a dimer in
the absence of DNA at all concentrations tested. In the presence
of DNA, cGAS forms a 2:2 complex with DNA in solution, consis-
tent with the crystal structure. A significant amount of this
complex was detectable only when both cGAS and DNA were
present at high concentrations, suggesting that the complex
has a poor association constant. This is consistent with the
fact that very few residues, notably K347 and K394 in human
cGAS, are involved in the protein-protein interface. Despite
this weak interaction, point mutation of either K347 or K394
completely abolishes the ability of cGAS to induce IFNb, under-
scoring the functional importance of forming the oligomeric com-
plex. While our paper was in revision, Li et al. (2013a) reported
that DNA binding induces oligomerization of cGAS that is impor-
tant for its activation. Consistent with our results, these authors
showed that mutations of cGAS at residues on the second
DNA binding surfaces and at the protein dimer interface abolish
cGAMP synthesis and IFNb induction. Although both studies
independently identified a common set of residues involved in
protein-DNA and protein-protein interactions, we identified and
validated additional key residues that are crucial for cGAS func-
tions. For example, we show that K411 and R353 are criticalNb Induction
(B). A series of positively charged patches in sulfate-bound cGAS indicate the
GAS fragments (161–522) containing alanine substitutions of positively charged
orter cells followed by luciferase assays to measure IFNb induction. Aliquots of
lectrophoresis (middle) or with a cGAS antibody flowing SDS-PAGE (bottom).
e located in the center of the primary binding surface.
e activation loop and the DNA, which likely triggers the inwardmovement of the
the steric clash or the movement of the activation loop. The activation loop is
are shown in sticks and colored in green.
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Figure 4. cGAS Forms a Functional 2:2 Complex with DNA
(A) Crystal structure of mouse cGAS in complex with a 16 bp dsDNA. Each asymmetric unit contains one 2:2 complex, composed of two protein molecules and
two DNA molecules. Two perpendicular views are shown.
(B) Electrostatic representations of the DNA binding surface 2 of mouse cGAS (left). Conserved positively charged residues are shown on the right, with the
corresponding residues in human cGAS shown in parentheses.
(legend continued on next page)
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residues in DNA binding surfaces 1 and 2, respectively. In addi-
tion, our results reveal the activation loop of cGAS that is impor-
tant for switching on the active-site rearrangement in response
to DNA binding. Future studies should determine whether and
how the formation of the cGAS oligomeric complex is regulated
in cells to provide a sensitive and timely response to DNA that
invades the cytoplasm.
EXPERIMENTAL PROCEDURES
Truncated human cGAS (147–522 in the apo form, and 161–522 in the 2030-
cGAMP-bound form and sulfate-bound form) and mouse cGAS (147–507)
were expressed in E. coli BL21 (DE3) pLysS as cleavable SUMO fusion pro-
teins. The recombinant proteins were purified by Ni2+-nitrilotriacetate affinity
resin (QIAGEN) followed by SUMO protease digestion at 4C overnight.
Further purification was applied on a Heparin column (GE Healthcare). The
peak fractions of the protein were collected and concentrated to 6 mg/ml for
crystallization trials. The selenomethionine-derivatized protein was purified
similarly as described above. All of the crystals were grown at 20C by the
hanging-drop vapor diffusion method. The data were collected at 19-ID at
the Advanced Photon Source (APS) or by using a Rigaku FR-E copper
rotating-anode generator and an R-AXIS IV2+ imaging-plate area detector
(Rigaku Americas). The data were integrated and scaled with the HKL2000
package (Otwinowski and Minor, 1997). Initial phases were generated using
anomalous differences of a 2.95 A˚ Se derivative data set by single-wavelength
anomalous dispersion (SAD). The phase information was improved by MR-
SAD using another 2.45 A˚ Se derivative data set. The initial model was built us-
ing the Autobuild suite aided by manual correction of the coordinates in COOT
(Emsley et al., 2010). The cGAMP-bound cGAS and sulfate-bound cGAS
structures were determined by MR using apo cGAS as the search model.
The mouse cGAS DNA complex structure was solved by MR using 4K98 as
the searchmodel. AUC experimentswere carried out using a BeckmanCoulter
Optima XL-I ultracentrifuge with samples in a buffer containing 25 mM Tris pH
8.0 and 25 mM NaCl. Data were acquired using both interference optics and
absorbance optics. To test the IFNb-inducing ability of different cGAS
mutants, expression plasmids were transfected into HEK293T-STING-IFNb
luciferase reporter cells. After 24 hr of transfection, the lysatewas used tomea-
sure firefly luciferase activity (Promega).
See the Supplemental Experimental Procedures for details.
ACCESSION NUMBERS
The coordinates of the structures of cGAS in its apo- and ligand-bound forms
have been deposited in the RCSBPDB under the following accession numbers
4O68 (human cGAS alone), 4O69 (sulfate-bound human cGAS), 4O67 (2030-
cGAMP-bound human cGAS), and 4O6A (DNA-bound mouse cGAS).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, one table, and fourmovies and can be foundwith this article online
at http://dx.doi.org/10.1016/j.celrep.2014.01.003.(C) Sulfate-bound human cGAS forms a dimer in the crystal (left); residues involve
mouse cGAS-DNA complex (upper right).
(D) AUC ofm-cGAS andDNA. Shown are c(s) distributions for various combination
DNA alone is also shown. The following concentrations were used: DNA alone, 1
K335E m-cGAS, 94 mM; and K335E m-cGAS/DNA, 94 mM and 120 mM, respective
(in fringes) present in the respective experiments. The arrows show the theoretic
(E) The second DNA binding surface and the protein-protein interface are importa
proteins as indicated were transfected into HEK293T-STING-IFNb luciferase repo
cell extracts were immunoblotted with an IRF3 antibody following native gel elect
error bars represent variation ranges of duplicate experiments.
See also Figure S4 and Movie S4.
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